Immunological Mechanisms in Breast Cancer - from Bench to Bedside

被引：1
作者：
Denkert, Carsten [1 ,2 ]
Schuetz, Florian [3 ]
机构：
[1] Charite, Inst Pathol, Berlin, Germany
[2] Charite, German Canc Consortium DKTK, Berlin, Germany
[3] Heidelberg Univ, Breast Canc Ctr, Heidelberg, Germany
来源：
BREAST CARE | 2016年 / 11卷 / 02期
关键词：
CHEMOTHERAPY;
D O I：
10.1159/000446266
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：93 / 94
页数：2
相关论文
共 50 条
[41]   Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach [J].
Masahiro Takada ;
Hiroshi Terunuma ;
Xuewen Deng ;
Md. Zahidunnabi Dewan ;
Shigehira Saji ;
Katsumasa Kuroi ;
Naoki Yamamoto ;
Masakazu Toi .
Breast Cancer, 2011, 18 :64-67
[42]   Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma [J].
Engels, C. C. ;
Fontein, D. B. Y. ;
Kuppen, P. J. K. ;
de Kruijf, E. M. ;
Smit, V. T. H. B. M. ;
Nortier, J. W. R. ;
Liefers, G. J. ;
van de Velde, C. J. H. ;
Bastiaannet, E. .
BRITISH JOURNAL OF CANCER, 2014, 111 (03) :532-538
[43]   Immunological Mechanisms of Low and Ultra-Low Dose Cancer Chemotherapy [J].
Landreneau, Joshua P. ;
Shurin, Michael R. ;
Agassandian, Marianna V. ;
Keskinov, Anton A. ;
Ma, Yang ;
Shurin, Galina V. .
CANCER MICROENVIRONMENT, 2015, 8 (02) :57-64
[44]   Mechanisms and consequences of chemotherapy resistance in breast cancer [J].
Coley, Helen M. .
EJC SUPPLEMENTS, 2009, 7 (01) :3-7
[45]   Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside [J].
Cho, Byung-Sik ;
Kim, Hee-Je ;
Konopleva, Marina .
KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (02) :248-257
[46]   Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice [J].
Zhang, Jinguo ;
Pan, Shuaikang ;
Jian, Chen ;
Hao, Li ;
Dong, Jie ;
Sun, Qingqing ;
Jin, Hongwei ;
Han, Xinghua .
FRONTIERS IN IMMUNOLOGY, 2022, 12
[47]   Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity - From Bench to Bedside [J].
Levi, Mattan ;
Goshen-Lago, Tal ;
Yerushalmi, Rinat ;
Granot, Tal ;
Stemmer, Salomon M. ;
Shalgi, Ruth ;
Ben-Aharon, Irit .
BIOMEDICINES, 2020, 8 (12) :1-11
[48]   Indications for an alternative effective treatment of head and neck squamous cell carcinoma with temsirolimus plus bevacizumab: from bench to bedside? [J].
Trafalis, Dimitrios T. ;
Alifieris, Constantinos ;
Dalezis, Panayiotis ;
Geromichalos, George ;
Sitaras, Nikolaos M. .
ANTI-CANCER DRUGS, 2012, 23 (08) :874-882
[49]   Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment [J].
Hanamura, Toru ;
Kitano, Shigehisa ;
Kagamu, Hiroshi ;
Yamashita, Makiko ;
Terao, Mayako ;
Okamura, Takuho ;
Kumaki, Nobue ;
Hozumi, Katsuto ;
Iwamoto, Takayuki ;
Honda, Chikako ;
Kurozumi, Sasagu ;
Niikura, Naoki .
BREAST CANCER RESEARCH, 2023, 25 (01)
[50]   GD2+ cancer stem cells in triple-negative breast cancer: mechanisms of resistance to breast cancer therapies [J].
Khoa Nguyen ;
McConnell, Emily ;
Edwards, Orielle ;
Collins-Burow, Bridgette M. ;
Burow, Matthew E. .
CANCER DRUG RESISTANCE, 2022, 5 (03) :721-726
12345